Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.

Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity...

Full description

Bibliographic Details
Main Authors: Chin-Chuen Lin, Yi-Yung Hung, Meng-Chang Tsai, Tiao-Lai Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5658162?pdf=render
_version_ 1831669158211747840
author Chin-Chuen Lin
Yi-Yung Hung
Meng-Chang Tsai
Tiao-Lai Huang
author_facet Chin-Chuen Lin
Yi-Yung Hung
Meng-Chang Tsai
Tiao-Lai Huang
author_sort Chin-Chuen Lin
collection DOAJ
description Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls.Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen had the diagnosis of schizophrenia, two had the diagnosis of major depressive disorder, two had bipolar disorder, one had postpartum depression, and one had herpes simplex encephalitis. No patient had catatonia during the follow-up. Nineteen sex-matched healthy controls were recruited.Using Mann-Whitney U test, patients had greater intensity of anti-NMDAR antibody immunofluorescence than the healthy controls (121,979 ± 86,526 vs. 47,692 ± 26,102, p = 0.003). No correlation was found between immunofluorescence intensity and catatonia scales or symptom severity scores. Neuropsychiatric patients with past catatonia showed greater anti-NMDAR antibody response than the healthy controls.NMDAR dysfunction might play a role in the mechanism underlying catatonia. Further studies are needed to confirm this finding.
first_indexed 2024-12-19T22:54:05Z
format Article
id doaj.art-b3b3b84fe1d4441cb88a74498f93162d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T22:54:05Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b3b3b84fe1d4441cb88a74498f93162d2022-12-21T20:02:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018715610.1371/journal.pone.0187156Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.Chin-Chuen LinYi-Yung HungMeng-Chang TsaiTiao-Lai HuangAnti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls.Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen had the diagnosis of schizophrenia, two had the diagnosis of major depressive disorder, two had bipolar disorder, one had postpartum depression, and one had herpes simplex encephalitis. No patient had catatonia during the follow-up. Nineteen sex-matched healthy controls were recruited.Using Mann-Whitney U test, patients had greater intensity of anti-NMDAR antibody immunofluorescence than the healthy controls (121,979 ± 86,526 vs. 47,692 ± 26,102, p = 0.003). No correlation was found between immunofluorescence intensity and catatonia scales or symptom severity scores. Neuropsychiatric patients with past catatonia showed greater anti-NMDAR antibody response than the healthy controls.NMDAR dysfunction might play a role in the mechanism underlying catatonia. Further studies are needed to confirm this finding.http://europepmc.org/articles/PMC5658162?pdf=render
spellingShingle Chin-Chuen Lin
Yi-Yung Hung
Meng-Chang Tsai
Tiao-Lai Huang
Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
PLoS ONE
title Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
title_full Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
title_fullStr Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
title_full_unstemmed Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
title_short Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.
title_sort increased serum anti n methyl d aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia
url http://europepmc.org/articles/PMC5658162?pdf=render
work_keys_str_mv AT chinchuenlin increasedserumantinmethyldaspartatereceptorantibodyimmunofluorescenceinpsychiatricpatientswithpastcatatonia
AT yiyunghung increasedserumantinmethyldaspartatereceptorantibodyimmunofluorescenceinpsychiatricpatientswithpastcatatonia
AT mengchangtsai increasedserumantinmethyldaspartatereceptorantibodyimmunofluorescenceinpsychiatricpatientswithpastcatatonia
AT tiaolaihuang increasedserumantinmethyldaspartatereceptorantibodyimmunofluorescenceinpsychiatricpatientswithpastcatatonia